Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients

AIM OF THE STUDY: Sunitinib-related side effects may develop as a result of the pharmacokinetic pathway affects the of the drug. MATERIAL AND METHODS: Data on mRCC patients were obtained from the hospital archives. Outcomes of patients were evaluated in terms of related prognostic factors, sunitinib...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Contemp Oncol (Pozn)
Asıl Yazarlar: Ordu, Çetin, Pilanci, Kezban N., Avcı, Nilüfer, Yıldız, İbrahim, Alço, Gül, Demirhan, Özkan, Köksal, Ülkühan I., Elbüken, Filiz, Tecimer, Coskun, Demir, Gökhan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Termedia Publishing House 2016
Konular:
Original Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4925734/
https://ncbi.nlm.nih.gov/pubmed/27358594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2016.60069
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller